Display options
Cite
Hackel MA, Karlowsky JA, Canino MA, et al. . Antimicrob Agents Chemother. 2021;aac0216521doi: 10.1128/aac.02165-21.
Hackel, M. A., Karlowsky, J. A., Canino, M. A., Sahm, D. F., & Scangarella-Oman, N. E. (2021). . Antimicrobial agents and chemotherapy, aac0216521. https://doi.org/10.1128/aac.02165-21
Hackel, Meredith A, et al. "." Antimicrobial agents and chemotherapy vol. (2021): aac0216521. doi: https://doi.org/10.1128/aac.02165-21
Hackel MA, Karlowsky JA, Canino MA, Sahm DF, Scangarella-Oman NE. . Antimicrob Agents Chemother. 2021 Dec 20;aac0216521. doi: 10.1128/aac.02165-21. Epub 2021 Dec 20. PMID: 34930028.
Copy Download .nbib Format: NLM
Share it on

Antimicrob Agents Chemother. 2021 Dec 20;aac0216521. doi: 10.1128/aac.02165-21. Epub 2021 Dec 20.

[No title available]

Antimicrobial agents and chemotherapy

Meredith A Hackel, James A Karlowsky, Michele A Canino, Daniel F Sahm, Nicole E Scangarella-Oman

Affiliations

  1. IHMA, Schaumburg, Illinois, USA.
  2. Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  3. GlaxoSmithKline, Collegeville, PA, USA.

PMID: 34930028 DOI: 10.1128/aac.02165-21

Abstract

Gepotidacin (formerly GSK2140944) is a first in class triazaacenaphthylene antibacterial currently in Phase III clinical trials. When tested against Gram-negative (

Publication Types